Fundz

Metaphore Biotechnologies Appoints Anabella Villalobos as Chief Scientific Officer

PRIVATESep 09, 2025

Position

Chief Scientific Officer

Company

Metaphore Biotechnologies

Anabella Villalobos
CambridgeBiotechnologyHealth CareArtificial Intelligence

Description

Metaphore Biotechnologies has announced the appointment of Anabella Villalobos, Ph.D., as Chief Scientific Officer. Villalobos will lead the advancement of the MIMIC™ platform and oversee the company's drug discovery and development efforts.

Quick answer

Metaphore Biotechnologies Appoints Anabella Villalobos as Chief Scientific Officer (September 9, 2025). Metaphore Biotechnologies is based in Cambridge, Massachusetts, United States.

Who is the new Chief Scientific Officer at Metaphore Biotechnologies?
Metaphore Biotechnologies named Anabella Villalobos Chief Scientific Officer, announced September 9, 2025.
What did Metaphore Biotechnologies announce on September 9, 2025?
Metaphore Biotechnologies has announced the appointment of Anabella Villalobos, Ph.D., as Chief Scientific Officer. Villalobos will lead the advancement of the MIMIC™ platform and oversee the company's drug discovery and development efforts.
What does Metaphore Biotechnologies do?
Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics.
Where is Metaphore Biotechnologies based?
Metaphore Biotechnologies is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Autonomize (September 11, 2025), Arthrolense (September 11, 2025), Formation Bio (September 18, 2025) and dorsaVi (August 28, 2025) also announced leadership changes within 45 days of Metaphore Biotechnologies.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Metaphore Biotechnologies, and when

A new leader at Metaphore Biotechnologies brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Metaphore Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Metaphore Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Metaphore Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Metaphore Biotechnologies

Location

Cambridge, Massachusetts, United States

About

Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Metaphore Biotechnologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Metaphore Biotechnologies's next move

Learn about Strategic plan

Metaphore Biotechnologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.